Washington University >> School of Medicine >>
  
Left Header Image Right Header Image Right Header Image Right Header Image
Skip Navigation Links
News
Faculty
Specialties
Research
Clinical Studies
 in 
 
Faculty Bio

King, Allison, M.D., M.P.H.

Assistant Professor of Pediatrics

Hematology/Oncology                                                                                                                           Program in Occupational Therapy      

Dr. King is a pediatric hematologist and oncologist.  She focuses her research on educational outcomes of two populations of children with chronic diseases: children with sickle cell disease and children with brain tumors.  She is investigating variables related to academic achievement and self-sufficiency.

King, Allison, M.D., M.P.H.

Assistant Professor of Pediatrics

Hematology/Oncology                                                                                                                           Program in Occupational Therapy      

Dr. King is a pediatric hematologist and oncologist.  She focuses her research on educational outcomes of two populations of children with chronic diseases: children with sickle cell disease and children with brain tumors.  She is investigating variables related to academic achievement and self-sufficiency.

Education
  • M.D., University of Missouri, Columbia, 1996
  • MPH, St. Louis University, 2003
  • M.D., University of Missouri, Columbia, 1996
  • MPH, St. Louis University, 2003
Training
  • Resident in Pediatrics, Washington University School of Medicine, St Louis, MO, 1996-1999
  • Fellow in Pediatric Hematology/Oncology, Washington University School of Medicine, St Louis, MO, 2000-2003
  • Resident in Pediatrics, Washington University School of Medicine, St Louis, MO, 1996-1999
  • Fellow in Pediatric Hematology/Oncology, Washington University School of Medicine, St Louis, MO, 2000-2003
Licensure and Board Certification
  • Missouri License, 1996
  • American Board of Pediatrics, 1999
  • Pediatric Hematology and Oncology, 2005
  • Missouri License, 1996
  • American Board of Pediatrics, 1999
  • Pediatric Hematology and Oncology, 2005
Honors
  • Jacob Javits Junior Investigator Award, 2005-2009
  • Jacob Javits Junior Investigator Award, 2005-2009
Selected Publications
  1. King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome, American Journal of Medical Genetics. 2003 Oct;122(2):95-9. 
  2. Herron S, Bacak SJ, King A, DeBaun MR. The pediatric forum: inadequate recognition of education resources required for high-risk students with sickle cell disease. Archives of Pediatrics & Adolescent Medicine, 2003 Jan 157(1):104.
  3. Mosse Y, Greshock J, King A, Khazi D, Weber BL, Maris JM. Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. Lancet Oncol. 2003 Dec;4(12):769-71.
  4. King A, Tang S, Ferguson K, DeBaun MR. An Education Program to Increase Teacher Knowledge About Sickle Cell Disease. Journal of School Health. 2005;75(1):11-14.
  5. King A, Herron S, McKinstry R, Bacak S, Armstrong M, White D, DeBaun M. A Multidisciplinary Health Care Team’s Efforts to Improve Educational Attainment in Children with Sickle Cell Anemia and Cerebral Infarcts. Journal of School Health, 2006, 76(1)33-37.
  6. Field JJ, Mason PJ, An P, Kasai Y, McLellan M, Jaeger S, Barnes YJ, King AA, Bessler M, Wilson DB. Low frequency of Telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome. J Ped Hem Oncol. 2006; 28(7) 450-453.
  7. Leonard JR, Perry A, Rubin JB, King AA, Chicoine MR, Gutmann DH. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology. 2006; Oct 24;67(8):1509-12.
  8. King AA, White DA, McKinstry RC, Noetzel M, DeBaun MR. A Pilot Randomized Education Rehabilitation Trial Is Feasible in Sickle Cell and Strokes. Neurology, 2007 Jun 5;68(23):2008-11.
  9. King AA, Noetzel M, White DA, McKinstry RC, DeBaun MR. Blood Transfusion Therapy is Feasible in a Clinical Trial Setting in Children with Sickle Cell Disease and Silent Cerebral Infarcts, Accepted, Pediatric Blood and Cancer, July 2007.

Book Chapters:

  1. DeBaun M.R. and King A. Clinical Studies in Pediatric Minority Patients. In: Translational and Experimental Clinical Research, Schuster, D. and Powers, W. (Ed.), Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 209-211.

 

  1. King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: The effect of presenting symptoms on outcome, American Journal of Medical Genetics. 2003 Oct;122(2):95-9. 
  2. Herron S, Bacak SJ, King A, DeBaun MR. The pediatric forum: inadequate recognition of education resources required for high-risk students with sickle cell disease. Archives of Pediatrics & Adolescent Medicine, 2003 Jan 157(1):104.
  3. Mosse Y, Greshock J, King A, Khazi D, Weber BL, Maris JM. Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma. Lancet Oncol. 2003 Dec;4(12):769-71.
  4. King A, Tang S, Ferguson K, DeBaun MR. An Education Program to Increase Teacher Knowledge About Sickle Cell Disease. Journal of School Health. 2005;75(1):11-14.
  5. King A, Herron S, McKinstry R, Bacak S, Armstrong M, White D, DeBaun M. A Multidisciplinary Health Care Team’s Efforts to Improve Educational Attainment in Children with Sickle Cell Anemia and Cerebral Infarcts. Journal of School Health, 2006, 76(1)33-37.
  6. Field JJ, Mason PJ, An P, Kasai Y, McLellan M, Jaeger S, Barnes YJ, King AA, Bessler M, Wilson DB. Low frequency of Telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome. J Ped Hem Oncol. 2006; 28(7) 450-453.
  7. Leonard JR, Perry A, Rubin JB, King AA, Chicoine MR, Gutmann DH. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology. 2006; Oct 24;67(8):1509-12.
  8. King AA, White DA, McKinstry RC, Noetzel M, DeBaun MR. A Pilot Randomized Education Rehabilitation Trial Is Feasible in Sickle Cell and Strokes. Neurology, 2007 Jun 5;68(23):2008-11.
  9. King AA, Noetzel M, White DA, McKinstry RC, DeBaun MR. Blood Transfusion Therapy is Feasible in a Clinical Trial Setting in Children with Sickle Cell Disease and Silent Cerebral Infarcts, Accepted, Pediatric Blood and Cancer, July 2007.

Book Chapters:

  1. DeBaun M.R. and King A. Clinical Studies in Pediatric Minority Patients. In: Translational and Experimental Clinical Research, Schuster, D. and Powers, W. (Ed.), Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 209-211.

 

 
dna
 
| Terms Of Use | Privacy Statement | Copyright 2009 by Washington University in St. Louis, School of Medicine | |